The Role of Pea3 Group Transcription Factors in Esophageal Squamous Cell Carcinoma
- 31 August 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 179 (2), 992-1003
- https://doi.org/10.1016/j.ajpath.2011.04.004
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
This publication has 59 references indexed in Scilit:
- Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinomaDiseases of the Esophagus, 2010
- Cyclooxygenase-2 Inhibitor NS398 Enhances Radiosensitivity of Radioresistant Esophageal Cancer Cells by Inhibiting AKT Activation and Inducing ApoptosisCancer Investigation, 2010
- Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1British Journal of Cancer, 2009
- Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regionsDiseases of the Esophagus, 2009
- Cyclooxygenase‐2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancerInternational Journal of Cancer, 2009
- Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicityJournal of Gastroenterology and Hepatology, 2009
- Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stressCarcinogenesis: Integrative Cancer Research, 2009
- The PEA3 Group of ETS-related Transcription FactorsAdvances in Experimental Medicine and Biology, 2002
- Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cellsOncogene, 2000
- The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2Published by Elsevier BV ,2000